You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

DUTASTERIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Dutasteride patents expire, and when can generic versions of Dutasteride launch?

Dutasteride is a drug marketed by Acella, Actavis Labs Fl Inc, Adaptis, Amneal Pharms, Apotex, Ascent Pharms Inc, Aurobindo Pharma Ltd, Barr, Chartwell, Heritage Pharms Inc, Hikma, Humanwell Puracap, Norvium Bioscience, Nostrum Labs Inc, Rising, Strides Pharma, Vintage, Zydus Lifesciences, Aurobindo Pharma, Endo Operations, and Zydus Pharms. and is included in twenty-three NDAs.

The generic ingredient in DUTASTERIDE is dutasteride; tamsulosin hydrochloride. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dutasteride; tamsulosin hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DUTASTERIDE?
  • What are the global sales for DUTASTERIDE?
  • What is Average Wholesale Price for DUTASTERIDE?
Drug patent expirations by year for DUTASTERIDE
Drug Prices for DUTASTERIDE

See drug prices for DUTASTERIDE

Drug Sales Revenue Trends for DUTASTERIDE

See drug sales revenues for DUTASTERIDE

Recent Clinical Trials for DUTASTERIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Masonic Cancer Center, University of MinnesotaPhase 2
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalPhase 2
Radboud University Medical CenterPhase 2

See all DUTASTERIDE clinical trials

Pharmacology for DUTASTERIDE
Medical Subject Heading (MeSH) Categories for DUTASTERIDE
Paragraph IV (Patent) Challenges for DUTASTERIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
AVODART Capsules dutasteride 0.5 mg 021319 1 2007-10-29

US Patents and Regulatory Information for DUTASTERIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acella DUTASTERIDE dutasteride CAPSULE;ORAL 206373-001 Mar 17, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Vintage DUTASTERIDE dutasteride CAPSULE;ORAL 202421-001 Nov 20, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd DUTASTERIDE dutasteride CAPSULE;ORAL 202660-001 Nov 20, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms DUTASTERIDE dutasteride CAPSULE;ORAL 203118-001 Nov 20, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Humanwell Puracap DUTASTERIDE dutasteride CAPSULE;ORAL 209909-001 Nov 21, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.